Cipla said it has received the nod from Central Drugs Standard Control Organisation (CDSCO) for the exclusive distribution and marketing of Afrezza - inhalation human insulin in India.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback